Alzheimer's disease (AD) is an enigmatic, neurodegenerative brain disorder that impairs memory, concentration, and even basic tasks. Every three seconds, a new AD case emerges worldwide, underscoring its widespread impact. Extensive research underscores the pivotal role of early AD detection in curtailing treatment expenses and duration. This study pioneers a dual approach, leveraging both Machine Learning and Deep Learning methodologies to prognosticate Alzheimer's through MRI images. Notably, the VGG16-based model achieves an impressive accuracy of 0.808, surpassing conventional machine learning models (SVM, RF, KNN, DT, NB, LR) and sophisticated deep learning counterparts (CNN, VGG16, ResNet50, MobileNet, DenseNet 121). This outcome presents a pivotal stride toward advancing Alzheimer's diagnosis and optimizing treatment strategies for enhanced patient care.
No takes yet. Share an insight, caveat, or question.
Manimuthu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: